logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Linda S Park

This inventor holds 16 USPTO granted patents. Top assignee: Immunex Corporation. Active years: 1991-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linda S Park. Retrieved from https://idiyas.com/inventor/linda-s-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 93.8

Average Co-Inventor Count = 2.8

ph-index = 12

Forward Citations = 723(Granted Patents)


Company Filing History:

goldMedal16 out of 451 
 
Immunex Corporation
 patents

Years Active: 1991-2008

Loading Chart...
16 patents (USPTO):Explore Patents
1. 7317090 - Antibodies to Interleukin-4 receptors and uses thereof (2008-01-08),
2. 6716587 - Antibodies to interleukin-4 receptors and uses thereof (2004-04-06),
3. 6548655 - Interleukin-4 receptors (2003-04-15),
4. 6391581 - DNA encoding interleukin-4 receptors (2002-05-21),
5. 5856296 - DNA encoding interleukin-4 receptors (1999-01-05),
6. 5840869 - DNA encoding interleukin-4 receptors (1998-11-24),
7. 5767065 - Use of interleukin-4 receptors to inhibit biological responses mediated (1998-06-16),
8. 5717072 - Antibodies that are immunoreactive with interleukin-4 receptors (1998-02-10),
9. 5599905 - Interleukin-4 receptors (1997-02-04),
10. 5543320 - Antibodies to interleuken-7 receptors (1996-08-06),
11. 5298395 - Hyperglycosylated cytokine conjugates (1994-03-29),
12. 5264416 - Interleukin-7 receptors (1993-11-23),
13. 5217881 - Hyperglycosylated cytokine conjugates (1993-06-08),
14. 5194375 - DNA encoding interleukin-7 receptors and methods of use (1993-03-16),
15. 5108910 - DNA sequences encoding fusion proteins comprising GM-CSF and IL-3 (1992-04-28),

Title: Innovations and Contributions of Linda S. Park

Introduction

Linda S. Park is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of immunology. With a total of 16 patents to her name, she has made remarkable advancements in the understanding and treatment of immune responses.

Latest Patents

Among her latest patents are "Antibodies to Interleukin-4 receptors and uses thereof," which discloses methods and compositions related to antibodies that bind to mammalian Interleukin-4 receptor proteins. Another notable patent is "A method for suppressing an IL-4-dependent immune or inflammatory response in a mammal," which involves administering an effective amount of soluble IL-4 receptor and a suitable diluent or carrier.

Career Highlights

Linda S. Park has built her career at Immunex Corporation, where she has been instrumental in developing innovative therapies. Her work has focused on creating solutions that target specific immune responses, contributing to advancements in medical treatments.

Collaborations

Throughout her career, Linda has collaborated with esteemed colleagues, including David J. Cosman and Bruce A. Mosley. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Linda S. Park's contributions to immunology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence the development of therapies that address immune-related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…